Tumour mutational burden and survival with molecularly matched therapy

The impact of tumour mutational burden (TMB) on outcome with molecularly matched therapy is unknown. Higher TMB could predict resistance to molecularly matched therapy through co-occurring driver mutations.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: De Bortoli, Till (VerfasserIn) , Benary, Manuela (VerfasserIn) , Horak, Peter (VerfasserIn) , Lamping, Mario (VerfasserIn) , Stintzing, Sebastian (VerfasserIn) , Tinhofer, Ingeborg (VerfasserIn) , Leyvraz, Serge (VerfasserIn) , Schäfer, Reinhold (VerfasserIn) , Klauschen, Frederick (VerfasserIn) , Keller, Ulrich (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn) , Fröhling, Stefan (VerfasserIn) , Kurzrock, Razelle (VerfasserIn) , Keilholz, Ulrich (VerfasserIn) , Rieke, Damian (VerfasserIn) , Jelas, Ivan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 2023
In: European journal of cancer
Year: 2023, Jahrgang: 190, Pages: 1-10
ISSN:1879-0852
DOI:10.1016/j.ejca.2023.05.013
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejca.2023.05.013
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804923002538
Volltext
Verfasserangaben:Till de Bortoli, Manuela Benary, Peter Horak, Mario Lamping, Sebastian Stintzing, Ingeborg Tinhofer, Serge Leyvraz, Reinhold Schäfer, Frederick Klauschen, Ulrich Keller, Albrecht Stenzinger, Stefan Fröhling, Razelle Kurzrock, Ulrich Keilholz, Damian T. Rieke, Ivan Jelas

MARC

LEADER 00000caa a2200000 c 4500
001 186263338X
003 DE-627
005 20240307050816.0
007 cr uuu---uuuuu
008 231012s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2023.05.013  |2 doi 
035 |a (DE-627)186263338X 
035 |a (DE-599)KXP186263338X 
035 |a (OCoLC)1425210307 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a De Bortoli, Till  |e VerfasserIn  |0 (DE-588)1313090743  |0 (DE-627)1873174284  |4 aut 
245 1 0 |a Tumour mutational burden and survival with molecularly matched therapy  |c Till de Bortoli, Manuela Benary, Peter Horak, Mario Lamping, Sebastian Stintzing, Ingeborg Tinhofer, Serge Leyvraz, Reinhold Schäfer, Frederick Klauschen, Ulrich Keller, Albrecht Stenzinger, Stefan Fröhling, Razelle Kurzrock, Ulrich Keilholz, Damian T. Rieke, Ivan Jelas 
264 1 |c September 2023 
300 |b Diagramme 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht am 4. August 2023 
500 |a Gesehen am 12.12.2023 
520 |a The impact of tumour mutational burden (TMB) on outcome with molecularly matched therapy is unknown. Higher TMB could predict resistance to molecularly matched therapy through co-occurring driver mutations. 
650 4 |a Molecular tumour board 
650 4 |a Personalised therapy 
650 4 |a Precision oncology 
650 4 |a Tumour mutational burden 
700 1 |a Benary, Manuela  |e VerfasserIn  |0 (DE-588)1084345803  |0 (DE-627)848517830  |0 (DE-576)456287728  |4 aut 
700 1 |a Horak, Peter  |e VerfasserIn  |0 (DE-588)1156426111  |0 (DE-627)1019252839  |0 (DE-576)502179961  |4 aut 
700 1 |a Lamping, Mario  |e VerfasserIn  |0 (DE-588)1261256719  |0 (DE-627)1808385802  |4 aut 
700 1 |a Stintzing, Sebastian  |d 1977-  |e VerfasserIn  |0 (DE-588)129819603  |0 (DE-627)481323066  |0 (DE-576)29785190X  |4 aut 
700 1 |a Tinhofer, Ingeborg  |e VerfasserIn  |0 (DE-588)1022646524  |0 (DE-627)717020274  |0 (DE-576)365732869  |4 aut 
700 1 |a Leyvraz, Serge  |e VerfasserIn  |4 aut 
700 1 |a Schäfer, Reinhold  |e VerfasserIn  |4 aut 
700 1 |a Klauschen, Frederick  |d 1974-  |e VerfasserIn  |0 (DE-588)129955779  |0 (DE-627)484980890  |0 (DE-576)297920766  |4 aut 
700 1 |a Keller, Ulrich  |d 1968-  |e VerfasserIn  |0 (DE-588)114692068  |0 (DE-627)52194161X  |0 (DE-576)289805279  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Fröhling, Stefan  |d 1969-  |e VerfasserIn  |0 (DE-588)120890046  |0 (DE-627)080950302  |0 (DE-576)188733930  |4 aut 
700 1 |a Kurzrock, Razelle  |d 1954-  |e VerfasserIn  |0 (DE-588)134284496  |0 (DE-627)566087715  |0 (DE-576)300424310  |4 aut 
700 1 |a Keilholz, Ulrich  |e VerfasserIn  |0 (DE-588)111152324X  |0 (DE-627)865593043  |0 (DE-576)161675387  |4 aut 
700 1 |a Rieke, Damian  |d 1988-  |e VerfasserIn  |0 (DE-588)1136749470  |0 (DE-627)89353661X  |0 (DE-576)490818641  |4 aut 
700 1 |a Jelas, Ivan  |e VerfasserIn  |0 (DE-588)1128614405  |0 (DE-627)882987348  |0 (DE-576)485947137  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 190(2023) vom: Sept., Artikel-ID 112925, Seite 1-10  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Tumour mutational burden and survival with molecularly matched therapy 
773 1 8 |g volume:190  |g year:2023  |g month:09  |g elocationid:112925  |g pages:1-10  |g extent:10  |a Tumour mutational burden and survival with molecularly matched therapy 
856 4 0 |u https://doi.org/10.1016/j.ejca.2023.05.013  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0959804923002538  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20231012 
993 |a Article 
994 |a 2023 
998 |g 111152324X  |a Keilholz, Ulrich  |m 111152324X:Keilholz, Ulrich  |p 13 
998 |g 120890046  |a Fröhling, Stefan  |m 120890046:Fröhling, Stefan  |d 50000  |e 50000PF120890046  |k 0/50000/  |p 12 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 11 
998 |g 1156426111  |a Horak, Peter  |m 1156426111:Horak, Peter  |d 50000  |e 50000PH1156426111  |k 0/50000/  |p 3 
999 |a KXP-PPN186263338X  |e 4385576866 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"September 2023"}],"physDesc":[{"extent":"10 S.","noteIll":"Diagramme"}],"relHost":[{"disp":"Tumour mutational burden and survival with molecularly matched therapyEuropean journal of cancer","language":["eng"],"titleAlt":[{"title":"EJC online"}],"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"part":{"volume":"190","text":"190(2023) vom: Sept., Artikel-ID 112925, Seite 1-10","extent":"10","year":"2023","pages":"1-10"},"origin":[{"dateIssuedDisp":"1992-","publisher":"Elsevier ; Pergamon Press","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1992"}],"pubHistory":["28.1992 -"],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","roleDisplay":"Herausgebendes Organ","role":"isb"},{"display":"European Association for Cancer Research","roleDisplay":"Herausgebendes Organ","role":"isb"},{"display":"European School of Oncology","roleDisplay":"Herausgebendes Organ","role":"isb"}],"id":{"issn":["1879-0852"],"eki":["266883400"],"zdb":["1468190-0"]},"recId":"266883400"}],"note":["Online veröffentlicht am 4. August 2023","Gesehen am 12.12.2023"],"language":["eng"],"recId":"186263338X","id":{"eki":["186263338X"],"doi":["10.1016/j.ejca.2023.05.013"]},"name":{"displayForm":["Till de Bortoli, Manuela Benary, Peter Horak, Mario Lamping, Sebastian Stintzing, Ingeborg Tinhofer, Serge Leyvraz, Reinhold Schäfer, Frederick Klauschen, Ulrich Keller, Albrecht Stenzinger, Stefan Fröhling, Razelle Kurzrock, Ulrich Keilholz, Damian T. Rieke, Ivan Jelas"]},"person":[{"role":"aut","display":"De Bortoli, Till","roleDisplay":"VerfasserIn","given":"Till","family":"De Bortoli"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Manuela","display":"Benary, Manuela","family":"Benary"},{"display":"Horak, Peter","roleDisplay":"VerfasserIn","given":"Peter","family":"Horak","role":"aut"},{"family":"Lamping","display":"Lamping, Mario","roleDisplay":"VerfasserIn","given":"Mario","role":"aut"},{"role":"aut","display":"Stintzing, Sebastian","roleDisplay":"VerfasserIn","given":"Sebastian","family":"Stintzing"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Ingeborg","display":"Tinhofer, Ingeborg","family":"Tinhofer"},{"display":"Leyvraz, Serge","roleDisplay":"VerfasserIn","given":"Serge","family":"Leyvraz","role":"aut"},{"given":"Reinhold","roleDisplay":"VerfasserIn","display":"Schäfer, Reinhold","family":"Schäfer","role":"aut"},{"family":"Klauschen","roleDisplay":"VerfasserIn","given":"Frederick","display":"Klauschen, Frederick","role":"aut"},{"role":"aut","family":"Keller","display":"Keller, Ulrich","roleDisplay":"VerfasserIn","given":"Ulrich"},{"role":"aut","family":"Stenzinger","roleDisplay":"VerfasserIn","display":"Stenzinger, Albrecht","given":"Albrecht"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Fröhling, Stefan","given":"Stefan","family":"Fröhling"},{"family":"Kurzrock","roleDisplay":"VerfasserIn","given":"Razelle","display":"Kurzrock, Razelle","role":"aut"},{"family":"Keilholz","roleDisplay":"VerfasserIn","display":"Keilholz, Ulrich","given":"Ulrich","role":"aut"},{"role":"aut","family":"Rieke","roleDisplay":"VerfasserIn","given":"Damian","display":"Rieke, Damian"},{"role":"aut","family":"Jelas","roleDisplay":"VerfasserIn","display":"Jelas, Ivan","given":"Ivan"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Tumour mutational burden and survival with molecularly matched therapy","title_sort":"Tumour mutational burden and survival with molecularly matched therapy"}]} 
SRT |a DEBORTOLITTUMOURMUTA2023